Viewing nowLarakacapsule 150 mg (Pregabalin)
Pregabalin 150mg
Hard capsule · Prescription medication
Yuyoung Pharmaceutical Co., Ltd.

MFDS item code 201109024 · Approved 2011.10.24 · Insurance code 648203500
Treatment of neuropathic pain and fibromyalgia; adjunctive treatment of partial seizures of epilepsy
This medication is used to treat peripheral and central neuropathic pain in adults. It is also used as an adjunct treatment for partial seizures in epilepsy patients with or without secondary generalization. Additionally, it is effective in alleviating the symptoms of fibromyalgia. In summary, this medication is used for neuropathic pain, partial seizures, and fibromyalgia.
The total daily dose of this medicine, expressed as pregabalin, is administered orally in 2 divided doses, with or without food. Since this medicine is primarily excreted by the kidneys, the dose should be adjusted in patients with impaired renal function. (See section ‘5. Patients with renal impairment’.) 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: The starting dose of this medicine may be 150 mg/day. Based on each patient’s response and tolerability, the dose may be increased to 300 mg/day after 3 to 7 days. If necessary, it may subsequently be increased at 7-day intervals to a maximum of 600 mg/day. 2) Central neuropathic pain Adults: The starting dose of this medicine may be 150 mg/day. Based on each patient’s response and tolerability, the dose may be increased to 300 mg/day after 1 week. After an additional week, it may be increased to the target daily dose of 600 mg. If the target daily dose is not tolerated, dose reduction may be considered. (See section ‘4. Discontinuation of treatment’.) 2. Epilepsy Adults: The starting dose of this medicine may be 150 mg/day. Based on each patient’s response and tolerability, the dose may be increased to 300 mg/day after 1 week. If necessary, it may subsequently be increased at 7-day intervals to a maximum of 600 mg/day. 3. Fibromyalgia The recommended dose of this medicine for fibromyalgia is 300 mg ~ 450 mg/day. The starting dose is 75 mg twice daily (150 mg/day), and based on efficacy and tolerability, it may be increased within 1 week to 150 mg twice daily (300 mg/day). For patients who do not experience sufficient benefit at a dose of 300 mg/day, the dose may be increased within 1 week to 225 mg twice daily (450 mg/day). Clinical studies have also been conducted at a dose of 600 mg/day, but there is no evidence of additional benefit or adequate tolerability at this dose. Considering the dose-dependent adverse reactions, doses exceeding 450 mg/day are not recommended. 4. Discontinuation of treatment Based on current clinical experience, if treatment with this medicine is discontinued, it should be tapered gradually over at least 1 week. 5. Patients with renal impairment After entering the systemic circulation, this medicine is primarily excreted by the kidneys unchanged. Since the clearance of this medicine is directly affected by creatinine clearance, dose reduction in patients with impaired renal function should be individualized based on creatinine clearance. Creatinine clearance [Table 1] is determined using the formula below. *: For women, multiply the result obtained using the above formula by 0.85. This medicine is effectively removed from plasma by hemodialysis (approximately 50% within 4 hours). In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose determined according to renal function, a supplemental dose should be administered promptly after each 4-hour hemodialysis session. [Table 1]. Pregabalin dosing based on renal function Creatinine clearance (CLcr), (mL/min) Total daily dose of pregabalin a Method of administration Starting dose (mg/day) Maximum dose (mg/day) ≥60: 150, 600, BID or TID ≥30 -<60: 75, 300, BID or TID ≥15 -<30: 25-50, 150, QD or BID <15: 25, 75, QD Supplemental dose after hemodialysis: 25, 100, single dose b TID = total daily dose divided into 3 doses BID = total daily dose divided into 2 doses QD = once daily a: The total daily dose (mg/day) should be divided as indicated under method of administration. b: Supplemental dose refers to an additional dose administered once. 6. Patients with hepatic impairment No dose adjustment is necessary in patients with hepatic impairment. 8. Elderly patients (65 years of age or older) Dose reduction may be necessary in elderly patients with impaired renal function.
Children under 12 years of age: Administration is not recommended because there are insufficient data on safety and efficacy. Adolescent patients aged 12 ~17 years: Administration is not recommended because there are insufficient data on safety and efficacy.
This medication may increase the risk of suicidal thoughts or behaviors, and any changes in mood or unusual behavior should be reported to a doctor immediately while taking it. Individuals with hypersensitivity to this medication or certain genetic disorders, such as lactose intolerance, should not take it. Diabetic patients should discuss dosage adjustments with their doctor due to potential weight gain affecting blood sugar control. If symptoms of angioedema appear, the medication should be stopped immediately and healthcare personnel should be notified. Elderly individuals should be cautious due to the risk of falls from dizziness or drowsiness, especially during the initial stages of treatment. Transient blurring of vision or changes in eyesight may occur, so consult a physician if unusual symptoms arise. Abrupt discontinuation of this medication can cause withdrawal symptoms such as insomnia, headache, and anxiety, so it should be tapered off gradually under medical guidance. Patients with a history of substance abuse may require special attention due to the potential for misuse or dependence on this medication. Patients with impaired kidney function should have their dosage adjusted, and patients with heart failure should also use this medication cautiously. When combined with opioid analgesics, there is an increased risk of central nervous system depression, thus caution is needed. Patients with compromised respiratory function or elderly patients have a risk of severe respiratory depression and should take this medication under the direction of healthcare personnel. During early pregnancy, there is a risk of fetal malformations, so women who are pregnant or planning to become pregnant should consult a physician and use effective contraception. For breastfeeding women, this medication may be passed into breast milk, hence they should discuss with their physician whether to discontinue breastfeeding or the medication. Tasks requiring concentration, such as driving or operating machinery, should be avoided until dizziness or drowsiness completely resolves. If serious allergic reactions such as skin rashes, fever, or difficulty in breathing occur while taking this medication, treatment should be stopped immediately and the hospital should be visited. In case of overdose, confusion, drowsiness, and depression may occur, so immediate medical attention should be sought.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. The storage temperature should be maintained between 15 degrees and 30 degrees Celsius.
A hard capsule with a white upper part and a white lower part containing a white powder that is white or light yellow in color.
Domestic use - 30 capsules/bottle, Domestic use - 60 capsules/bottle, Export use - 100 capsules/bottle, Export use - 30 capsules/PTP, Export use - 100 capsules/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 150mg
Hard capsule · Prescription medication
Yuyoung Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.